# A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005)

> **NCT00282763** · PHASE2 · TERMINATED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 12 (actual)

## Conditions studied

- Neuralgia, Postherpetic

## Interventions

- **DRUG:** MK0686

## Key facts

- **NCT ID:** NCT00282763
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-12
- **Primary completion:** 2006-08
- **Final completion:** 2006-08
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00282763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00282763, "A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00282763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*